Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: A matter of dose and inflammation

Gian Luca Erre; Edoardo Sean Ferraccioli; Matteo Piga; Arduino Mangoni; Giuseppe Passiu; Elisa Gremese; Gianfranco Ferraccioli

doi:10.1136/annrheumdis-2020-217828

Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: A matter of dose and inflammation

Gian Luca Erre, Edoardo Sean Ferraccioli, Matteo Piga, Arduino Mangoni, Giuseppe Passiu, Elisa Gremese, Gianfranco Ferraccioli

IRCCS Fondazione Policlinico Universitario A. Gemelli

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e217828
Journal	Annals of the Rheumatic Diseases
Volume	80
Issue number	3
DOIs	https://doi.org/10.1136/annrheumdis-2020-217828
Publication status	Published - Mar 1 2021

Keywords

antirheumatic agents
cardiovascular diseases
hydroxychloroquine

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology
Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1136/annrheumdis-2020-217828

Cite this

Antimalarial use and arrhythmias in COVID-19 and rheumatic patients : A matter of dose and inflammation. / Erre, Gian Luca; Ferraccioli, Edoardo Sean; Piga, Matteo; Mangoni, Arduino; Passiu, Giuseppe; Gremese, Elisa; Ferraccioli, Gianfranco.

In: Annals of the Rheumatic Diseases, Vol. 80, No. 3, e217828, 01.03.2021.

Research output: Contribution to journal › Letter › peer-review

@article{711b0b81ebd94ccabd4bab0dbf745a39,

title = "Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: A matter of dose and inflammation",

keywords = "antirheumatic agents, cardiovascular diseases, hydroxychloroquine",

author = "Erre, {Gian Luca} and Ferraccioli, {Edoardo Sean} and Matteo Piga and Arduino Mangoni and Giuseppe Passiu and Elisa Gremese and Gianfranco Ferraccioli",

note = "Funding Information: Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis study). ClinicalTrials.gov: NCT02341066. The EDRA study is a project funded by the Italian Ministry of Health and by the Regione Sardegna (RAS): GR-2011-02352816, Ricerca Finalizzata 2011. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = mar,

day = "1",

doi = "10.1136/annrheumdis-2020-217828",

language = "English",

volume = "80",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Antimalarial use and arrhythmias in COVID-19 and rheumatic patients

T2 - A matter of dose and inflammation

AU - Erre, Gian Luca

AU - Ferraccioli, Edoardo Sean

AU - Piga, Matteo

AU - Mangoni, Arduino

AU - Passiu, Giuseppe

AU - Gremese, Elisa

AU - Ferraccioli, Gianfranco

N1 - Funding Information: Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis study). ClinicalTrials.gov: NCT02341066. The EDRA study is a project funded by the Italian Ministry of Health and by the Regione Sardegna (RAS): GR-2011-02352816, Ricerca Finalizzata 2011. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/3/1

Y1 - 2021/3/1

KW - antirheumatic agents

KW - cardiovascular diseases

KW - hydroxychloroquine

UR - http://www.scopus.com/inward/record.url?scp=85085646243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085646243&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2020-217828

DO - 10.1136/annrheumdis-2020-217828

M3 - Letter

C2 - 32424028

AN - SCOPUS:85085646243

VL - 80

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 3

M1 - e217828

ER -

Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: A matter of dose and inflammation

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this